PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 7, Pages 1770
Publisher
MDPI AG
Online
2022-04-01
DOI
10.3390/cancers14071770
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT
- (2021) Cem Onal et al. CLINICAL NUCLEAR MEDICINE
- Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
- (2021) Katherine A. Zukotynski et al. JOURNAL OF NUCLEAR MEDICINE
- Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?
- (2021) Duygu Has Simsek et al. ANNALS OF NUCLEAR MEDICINE
- Predicting the Risk of Metastases by PSMA-PET/CT—Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma
- (2021) Stefan A. Koerber et al. Cancers
- Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
- (2020) Ann-Kathrin Oehus et al. BMC CANCER
- Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer
- (2020) Stefan A. Koerber et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy
- (2020) Christoph Henkenberens et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer
- (2020) Angelyn Anton et al. BJU INTERNATIONAL
- Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer
- (2020) Sarah Bergamin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Treatment outcomes of metastasis-directed treatment using 68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)
- (2020) Pervin Hurmuz et al. STRAHLENTHERAPIE UND ONKOLOGIE
- 68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer
- (2020) Goda Kalinauskaite et al. PLoS One
- Prognostic Value of 18F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223
- (2020) Luca Filippi et al. Biomedicines
- 68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy
- (2019) C. Artigas et al. WORLD JOURNAL OF UROLOGY
- Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
- (2019) E. Quaquarini et al. Contrast Media & Molecular Imaging
- Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients
- (2019) Nicolas Plouznikoff et al. ANNALS OF NUCLEAR MEDICINE
- [18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer
- (2019) Francesco Pasqualetti et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy. Results of a prospective multi-center trial.
- (2019) Louise Emmett et al. JOURNAL OF NUCLEAR MEDICINE
- PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years
- (2019) Thomas Philip Shakespeare et al. RADIOTHERAPY AND ONCOLOGY
- Baseline 18F-Fluorocholine PET/CT and bone scan in the outcome prediction of patients treated with radium 223 dichloride
- (2018) A. M. García Vicente et al. Clinical & Translational Oncology
- Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy
- (2018) Nina-Sophie Schmidt-Hegemann et al. Radiation Oncology
- Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT
- (2018) Marsha Schlenter et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Therapy assessment in prostate cancer using choline and PSMA PET/CT
- (2017) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy
- (2017) Anna Katharina Seitz et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Treatment Outcomes from68Ga-PSMA PET/CT–Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET
- (2017) Louise Emmett et al. JOURNAL OF NUCLEAR MEDICINE
- Oligometastases in prostate cancer
- (2017) René Baumann et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer
- (2016) Andrei Fodor et al. BJU INTERNATIONAL
- Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer
- (2016) Sarah M. Schwarzenböck et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers
- (2016) Francesca Maines et al. Future Oncology
- 68 Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with 223 Ra: Proof of Concept
- (2016) Hojjat Ahmadzadehfar et al. JOURNAL OF NUCLEAR MEDICINE
- [11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy
- (2016) Sarah M. Schwarzenböck et al. Oncotarget
- PSA Flare With Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2015) Salvatore L. Burgio et al. Clinical Genitourinary Cancer
- 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide
- (2015) Ugo De Giorgi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel
- (2015) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Nomogram Predicting Prostate Cancer–specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy
- (2015) John A. Brockman et al. EUROPEAN UROLOGY
- Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?
- (2015) E. Incerti et al. JOURNAL OF NUCLEAR MEDICINE
- Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone
- (2015) Ugo De Giorgi et al. Oncotarget
- Impact of Enzalutamide Administration on Primary Prostate Cancer Volume: A Metabolic Evaluation by Choline Positron Emission Tomography in Castration-Resistant Prostate Cancer Patients
- (2014) Orazio Caffo et al. Clinical Genitourinary Cancer
- Visceral Disease in Castration-resistant Prostate Cancer
- (2013) Carmel J. Pezaro et al. EUROPEAN UROLOGY
- Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls
- (2012) Dow-Mu Koh et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Correlation Between Serum Prostate-specific Antigen and Cancer Volume in Prostate Glands of Different Sizes
- (2010) Gustavo F. Carvalhal et al. UROLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started